Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 1
1987 2
1988 1
1989 1
1990 5
1991 2
1992 7
1993 5
1994 1
1995 2
1996 3
1997 6
1998 5
1999 10
2000 13
2001 12
2002 20
2003 12
2004 21
2005 16
2006 19
2007 19
2008 20
2009 16
2010 17
2011 24
2012 25
2013 20
2014 22
2015 17
2016 21
2017 12
2018 14
2019 12
2020 10
2021 13
2022 7
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C, Sargent A, Kitchener HC, Peto J. Gilham C, et al. Health Technol Assess. 2019 Jun;23(28):1-44. doi: 10.3310/hta23280. Health Technol Assess. 2019. PMID: 31219027 Free PMC article. Clinical Trial.
Options include extending the screening interval up to 10 years for human papillomavirus-negative (HPV-) women, delaying recall for human papillomavirus-positive (HPV+) women with normal cytology (as their infections are usually transient), and basing …
Options include extending the screening interval up to 10 years for human papillomavirus-negative (HPV-) women, delaying recal …
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.
Valls J, Baena A, Venegas G, Celis M, González M, Sosa C, Santin JL, Ortega M, Soilán A, Turcios E, Figueroa J, Rodríguez de la Peña M, Figueredo A, Beracochea AV, Pérez N, Martínez-Better J, Lora O, Jiménez JY, Giménez D, Fleider L, Salgado Y, Martínez S, Bellido-Fuentes Y, Flores B, Tatti S, Villagra V, Cruz-Valdez A, Terán C, Sánchez GI, Rodríguez G, Picconi MA, Ferrera A, Mendoza L, Calderón A, Murillo R, Wiesner C, Broutet N, Luciani S, Pérez C, Darragh TM, Jerónimo J, Herrero R, Almonte M; ESTAMPA study group. Valls J, et al. Lancet Glob Health. 2023 Mar;11(3):e350-e360. doi: 10.1016/S2214-109X(22)00545-9. Lancet Glob Health. 2023. PMID: 36796982 Free PMC article.
BACKGROUND: Colposcopy, currently included in WHO recommendations as an option to triage human papillomavirus (HPV)-positive women, remains as the reference standard to guide both biopsy for confirmation of cervical precancer and cancer and treatment approach …
BACKGROUND: Colposcopy, currently included in WHO recommendations as an option to triage human papillomavirus (HPV)-positive w …
Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F. Kasap B, et al. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21764503
OBJECTIVES: This study aimed to detect the presence and prevalence of HPV-DNA in the cervical swab samples obtained from patients with cervical cancer, premalignant cervical lesions and benign cervical smear results, and to identify the p …
OBJECTIVES: This study aimed to detect the presence and prevalence of HPV-DNA in the cervical swab samples obtained from patie …
Human Papillomavirus (HPV) Prevalence, Temporal Dynamics and Association with Abnormal Cervical Cytology Findings in Women from Croatia: Is there a Compounding Effect of Low-Risk/High-Risk HPV Co-Infection?
Meštrović T, Ljubin-Sternak S, Božičević I, Drenjančević D, Barać A, Kozina G, Neuberg M, Vraneš J. Meštrović T, et al. Clin Lab. 2020 Dec 1;66(12). doi: 10.7754/Clin.Lab.2020.200406. Clin Lab. 2020. PMID: 33337847
BACKGROUND: Human papillomavirus (HPV) is a major risk factor for cervical dysplasia and invasive cervical cancer; therefore, regular screening by cervical smear cytology or HPV testing is recommended. ...Digene HC2 HPV DNA test …
BACKGROUND: Human papillomavirus (HPV) is a major risk factor for cervical dysplasia and invasive cervical cance …
Human papillomavirus testing in the prevention of cervical cancer.
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Schiffman M, et al. J Natl Cancer Inst. 2011 Mar 2;103(5):368-83. doi: 10.1093/jnci/djq562. Epub 2011 Jan 31. J Natl Cancer Inst. 2011. PMID: 21282563 Free PMC article. Review.
Strong evidence now supports the adoption of cervical cancer prevention strategies that explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV). ...Thus, HPV test results predict the risk of cervical cancer and …
Strong evidence now supports the adoption of cervical cancer prevention strategies that explicitly focus on persistent infection with …
A Comprehensive Review of Cervical Cancer Screening Devices: The Pros and the Cons.
Hon HJ, Chong PP, Choo HL, Khine PP. Hon HJ, et al. Asian Pac J Cancer Prev. 2023 Jul 1;24(7):2207-2215. doi: 10.31557/APJCP.2023.24.7.2207. Asian Pac J Cancer Prev. 2023. PMID: 37505749 Free PMC article. Review.
OBJECTIVE: The low screening coverage and reluctance of women in participation lead to low uptake in cervical screening tests. Hence the majority of cervical cancer patients visiting the hospitals are diagnosed at advanced stage, often leading to poor survival rate. …
OBJECTIVE: The low screening coverage and reluctance of women in participation lead to low uptake in cervical screening tests. Hence …
A comparison of high-risk human papillomavirus DNA detection between urine and cervical sample testing in women with abnormal Pap smears.
Punyashthira A, Horthongkham N, Jaishuen A, Jareemit N, Achariyapota V. Punyashthira A, et al. J Obstet Gynaecol Res. 2022 Feb;48(2):448-455. doi: 10.1111/jog.15095. Epub 2021 Nov 8. J Obstet Gynaecol Res. 2022. PMID: 34750932
AIMS: To compare the clinical performance of high-risk human papillomavirus (hrHPV) DNA detection between urine and cervical samples collected from the same patient for the detection of CIN2+ lesions (high-grade squamous intraepithelial lesions or c …
AIMS: To compare the clinical performance of high-risk human papillomavirus (hrHPV) DNA detection between urine and …
Human papillomavirus in cervical screening and vaccination.
Crosbie EJ, Kitchener HC. Crosbie EJ, et al. Clin Sci (Lond). 2006 May;110(5):543-52. doi: 10.1042/CS20050230. Clin Sci (Lond). 2006. PMID: 16597323 Review.
The recognized importance of high-risk HPV (human papillomavirus) infection in the aetiology of cervical cancer may introduce a role for HPV DNA testing in cervical screening programmes. Positive HPV DNA tests indicate women at risk of …
The recognized importance of high-risk HPV (human papillomavirus) infection in the aetiology of cervical cancer may int …
Clinical correlation of cervical cancer screening using Pap smear test.
Sharif YH. Sharif YH. J Popul Ther Clin Pharmacol. 2022 Feb 15;29(1):e1-e8. doi: 10.47750/jptcp.2022.892. eCollection 2022. J Popul Ther Clin Pharmacol. 2022. PMID: 35686892
These results were used to perform a polymerase chain reaction (PCR) test to detect the presence of human papillomavirus (HPV) of (6 and 11), a low-risk type, and (16 and 18), a high-risk type with colposcopy examination and colposcopy-guided biopsy, if neede …
These results were used to perform a polymerase chain reaction (PCR) test to detect the presence of human papillomavirus …
Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
Dehn D, Torkko KC, Shroyer KR. Dehn D, et al. Cancer. 2007 Feb 25;111(1):1-14. doi: 10.1002/cncr.22425. Cancer. 2007. PMID: 17219448 Free article. Review.
Human papillomavirus (HPV) is the etiologic agent for the vast majority of premalignant and malignant lesions, and high-risk HPV types can be detected in almost all cases of cervical dysplasia and carcinoma. ...Although cervical cytology is a highly ef …
Human papillomavirus (HPV) is the etiologic agent for the vast majority of premalignant and malignant lesions, and high-risk H …
429 results